Table 2.

Primary and secondary outcomes

	Baseline	6 months	12 months
Complete remission	NA	10/15 (67%)	10/15 (67%)
Partial response	NA	3/15 (20%)	4/15 (27%)
Median cumulative prednisolone dose	NA	3.1 g (1–5.7)	4.7 g (1.9–7.9)
Total relapses	NA	2/15 (13%)	4/15 (27%)
Drug intolerance	NA	Nil reported	Nil reported
Median eosinophils count × 109/l (IQR)	3.48 (0.01–21)	0.2 (0.02–1)	0.16 (0.01–0.65)
Median CRP mg/L (IQR)	13.5 (< 4–113)	< 4 (1–12)	< 4 (< 4–120)